Advancements and Future Prospects of Energy Harvesting Technology in Power Systems. [PDF]
Du H +8 more
europepmc +1 more source
This study aimed to evaluate the prognostic value of ELN2017 in predicting survival outcomes and to assess the impact of clinical and molecular factors such as age, FLT3 and NPM1 mutations, and allogeneic hematopoietic stem cell transplantation (allo‐HSCT).
Mobina Shrestha +4 more
wiley +1 more source
Edge Temporal Digital Twin Network for Sensor-Driven Fault Detection in Nuclear Power Systems. [PDF]
Liu S, Ye G, Zhao X.
europepmc +1 more source
Visual Recovery Reflects Cortical MeCP2 Sensitivity in Rett Syndrome
ABSTRACT Objective Rett syndrome (RTT) is a devastating neurodevelopmental disorder with developmental regression affecting motor, sensory, and cognitive functions. Sensory disruptions contribute to the complex behavioral and cognitive difficulties and represent an important target for therapeutic interventions.
Alex Joseph Simon +12 more
wiley +1 more source
Decomposing sources of value for electricity and negative emissions technologies in net-zero power systems. [PDF]
Steinberg DC +4 more
europepmc +1 more source
Design and Simulation of Robust Controllers for Power Electronic Converters used in New Energy Architecture for a (PVG)/ (WTG) Hybrid System [PDF]
Mohamed Akram +2 more
openalex +1 more source
Network Localization of Fatigue in Multiple Sclerosis
ABSTRACT Background Fatigue is among the most common symptoms and one of the main factors determining the quality of life in multiple sclerosis (MS). However, the neurobiological mechanisms underlying fatigue are not fully understood. Here we studied lesion locations and their connections in individuals with MS, aiming to identify brain networks ...
Olli Likitalo +12 more
wiley +1 more source
Optimal AGC regulators for power systems under restructured configuration with hybrid ESS. [PDF]
Mishra RN +3 more
europepmc +1 more source
Real‐World Investigation of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disease
ABSTRACT Objective Satralizumab, a monoclonal antibody targeting the interleukin‐6 receptor, has demonstrated efficacy in clinical trials for neuromyelitis optica spectrum disorder (NMOSD). However, its real‐world effectiveness and safety compared to conventional immunosuppressive therapies remain uncertain.
Li‐Tsung Lin +2 more
wiley +1 more source
Temporally consistent tri ledger settlement enables robust and noncontestable coordination in interprovincial power systems. [PDF]
Ma X, Lv S, Hu W, Huang C, Tan Z.
europepmc +1 more source

